Clinical Trial Update: Evaluation of Safety and Efficacy of Deoxycholic Acid Injection (ATX-101) in the Reduction of Submental Fat [Phase 3]

View source ↗

Summary

Phase 3 evaluation of deoxycholic acid injection (ATX-101) for reduction of submental fat shows safety and efficacy results in adults with moderate to severe su…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Submental Fullness

Drugs mentioned

• KYTHERA (ATX-101) (deoxycholic acid injection)

Snippet

Sponsor: Kythera Biopharmaceuticals | Conditions: Moderate or Severe Submental Fullness | Phase 3 | Status: COMPLETED | Results posted: 2015-06-15